Top

Published in:

01-11-2002

T1 Breast Cancer: Identification of Patients at Low Risk of Axillary Lymph Node Metastases

Authors: Arnim A. Bader, Joke Tio, Edgar Petru, Michael Bühner, Annette Pfahlberg, Hildegard Volkholz, Augustinus H. Tulusan

Published in: Breast Cancer Research and Treatment | Issue 1/2002

Title: T1 Breast Cancer: Identification of Patients at Low Risk of Axillary Lymph Node Metastases
Authors: Arnim A. Bader
Joke Tio
Edgar Petru
Michael Bühner
Annette Pfahlberg
Hildegard Volkholz
Augustinus H. Tulusan
Publication date: 01-11-2002
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 1/2002
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1020231300974

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2002

Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy

Instructions for Authors

Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database

Cyclooxygenase Inhibitors Block Cell Growth, Increase Ceramide and Inhibit Cell Cycle

Influence of Cimicifuga Racemosa on the Proliferation of Estrogen Receptor-Positive Human Breast Cancer Cells

Predictors of Sensitivity of Clinical Breast Examination (CBE)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer